Video from AACC: PerkinElmer on diagnostics, acquisitions

By Leo O'Connor, Editor in Chief

Greg Stock, general manager of PerkinElmer’s Euroimmun business, discussed products and technologies on display at AACC 2022, as well as the integration of acquired companies such as Oxford Immunotec.

Click on the video below for the interview.

PerkinElmer interview at AACC

Greg Stock, general manager of PerkinElmer's Euroimmun business.

If you like this content, please share it with a colleague!

Related Reading

Video from AACC: Beckman Coulter partners with Scopio
Danaher’s Beckman Coulter Diagnostics has announced it has partnered with Scopio Labs to accelerate adoption of Scopio's next-generation peripheral blood...

Video from AACC: AACC president on Theranos, VALID Act
Dr. Stephen Master, president of the American Association for Clinical Chemistry, provided his thoughts about the main highlights of the 2022 AACC Annual...

Video from AACC: Enzo BioChem CEO on COVID-19 test landscape
Enzo BioChem develops diagnostic tests and provides testing in centers throughout New York and its surrounding areas. CEO Hamid Erfanian spoke to us at...

Video from AACC: Cytovale immune-response test for sepsis
Cytovale CEO Ajay Shah discusses unmet needs in the sepsis testing market and the firm’s 10-minute direct-from-blood IntelliSep test.

Video from AACC: Reducing sequencing complexity
Clear Labs Chief Commercial Officer Jeff Field and Director of Assay Development Prasanna Thwar sat down with LabPulse.com (sister site of ScienceBoard.net)...